YU9099A - Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one for producting a pharmaceutical preparation for treatment of the alzheimer's disease - Google Patents

Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one for producting a pharmaceutical preparation for treatment of the alzheimer's disease

Info

Publication number
YU9099A
YU9099A YU9099A YU9099A YU9099A YU 9099 A YU9099 A YU 9099A YU 9099 A YU9099 A YU 9099A YU 9099 A YU9099 A YU 9099A YU 9099 A YU9099 A YU 9099A
Authority
YU
Yugoslavia
Prior art keywords
pharmaceutical preparation
benzisoselenazol
alzheimer
phenyl
disease
Prior art date
Application number
YU9099A
Other languages
Serbo-Croatian (sh)
Serbian (sr)
Inventor
Ikuo Maruyama
Kazuhiro Abeyama
Hiroyuku Masayasu
Original Assignee
A.Nattermann & Cie.Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A.Nattermann & Cie.Gmbh. filed Critical A.Nattermann & Cie.Gmbh.
Publication of YU9099A publication Critical patent/YU9099A/en
Publication of RS49595B publication Critical patent/RS49595B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Prikazani pronalazak odnosi se na jedan farmaceutski preparat za sprečavanje i/ili lečenje Alzhajmerove bolesti. Farmaceutski preparat sadrži kao aktivnu materiju 2-fenil-1,2-benzizoselenazol-3(2H)-on (naznačen kao jedinjenje A) čija je efikasnost na smanjenju neuronske toksičnosti izazvane -amiloidnim proteinom dokazana.The present invention relates to one pharmaceutical preparation for the prevention and / or treatment of Alzheimer's disease. The pharmaceutical preparation contains, as active ingredient, 2-phenyl-1,2-benzisoselenazol-3 (2H) -one (designated compound A), the efficacy of which has been demonstrated to reduce the neuronal toxicity induced by the -amyloid protein.

YUP-90/99A 1996-08-27 1999-02-19 Use of 2-phenyl-1,2-benzisoselenazol- 3(2h)-one for producing a pharmaceutical preparation intended for treatment of alzheimer’s disease RS49595B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22551208 1996-08-27

Publications (2)

Publication Number Publication Date
YU9099A true YU9099A (en) 1999-11-22
RS49595B RS49595B (en) 2007-06-04

Family

ID=43646406

Country Status (1)

Country Link
RS (1) RS49595B (en)

Also Published As

Publication number Publication date
RS49595B (en) 2007-06-04

Similar Documents

Publication Publication Date Title
NO20042298L (en) Pharmaceutical preparations and their uses
WO2002042462A3 (en) Therapeutic agents and methods of use thereof for treating an amyloidogenic disease
DOP2002000429A (en) IMIDAZOTRIAZINAS
CY1108514T1 (en) 1-PHENYLCANECARVOXYLIC ACID DERIVATIVE FOR TREATMENT OF NEUROLOGICAL DISEASES
AP2004003069A0 (en) 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof.
WO2002002505A3 (en) Compounds to treat alzheimer's disease
WO2002002512A3 (en) Compounds to treat alzheimer's disease
SE9701398D0 (en) Novel compounds
HUP9801240A2 (en) Oral compositions
JO3404B1 (en) Liquid pharmaceutical composition containing an erythropoietin derivative
NZ284846A (en) 1-substituted-pyrazolo[3,4-b]pyridin-5-carboxylic acid derivatives, preparation, use, intermediates and pharmaceutical compositions thereof
BR0210122A (en) Compound or a pharmaceutically acceptable salt thereof, method for treating or preventing a disease, use of the compound or salt thereof, and method for preparing the same
WO2005051914A8 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
TR200101649T2 (en) Piperazine derivatives.
DE69834500D1 (en) XANTHINE DERIVATIVES FOR THE TREATMENT OF BRAINISHEMIA
CA2213794A1 (en) Preventive or therapeutic drug for alzheimer's disease
TR200100637T2 (en) New natural product derivatives
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
PT1147105E (en) DERIVATIVES OF OPTICALLY ACTIVE PYRIDYL-4H-1,2,4-OXADIAZINE AND THEIR USE IN THE TREATMENT OF VASCULAR DISEASES
HUP9902415A2 (en) Solid instant-release forms of administration and process for producing the same
YU9099A (en) Use of 2-phenyl-1,2-benzisoselenazol-3(2h)-one for producting a pharmaceutical preparation for treatment of the alzheimer's disease
BR0213463A (en) Macrolide-containing pharmaceutical compositions
BR0209455A (en) Dentifrice
WO2001039573A3 (en) Novel use of lung surfactant for treating legionnaire's disease